Isma Benattia, M.D., MBA, currently serves as the Head of Medical for the European headquarters and affiliate Medical teams, across all therapeutic areas. Isma is very passionate about patient involvement in the Research & Development of innovative medicines, the life-cycle management of marketed products and is working extensively with various stakeholders to involve patients in the benefit-risk assessment of medicines.
Prior to her current role, Isma was responsible for advancing Amgen’s leadership in Global Patient Safety & Labeling. With over 20 years of industry experience, she has held various roles with increasing level of responsibility in different organizations. Prior to joining Amgen, she served as Vice President and Head of Safety Surveillance and Risk Management at Sanofi Genzyme. She has also worked in Clinical Development, Marketing, Medical Affairs and Executive Management at Eli Lilly France, Pfizer, and Wyeth Pharmaceuticals.
Isma Benattia received her medical degree from Faculte de Medecine d’Alger and Faculte de Medecine Pitie Salpetriere Paris, specializing in Psychiatry with a focus on the pharmacology of psychotropics. She also earned Master of Business Administration at the Massachusetts Institute of Technology Sloan School of Management, as well as Master in Bioethics from the University of Pennsylvania